Self-nanoemulsifying drug delivery systems (SNEDDS) have been proved as technologically worthwhile, effortlessly scalable and economically sound delivery systems for enhancing the oral bioavailability of highly lipophilic drugs. Distinct merits of smaller globule size, higher solubilization tendency and robust formulation advantages have made them as one of the most promising alternatives among the diverse lipid-based nanostructured systems. In the last two decades, the phenomenal success of SNEDDS as a potential delivery platform for oral delivery of drugs has gained phenomenal interest in...